March 17, 2023, 2 p.m. | MIT Technology Review Insights

MIT Technology Review www.technologyreview.com

Regeneron Pharmaceuticals, a biotechnology company that develops life-transforming medicines, found itself inundated with vast volumes of data during the peak of the covid-19 pandemic. In order to derive actionable information from these disparate data sets, which ranged from clinical trial data to real-time supply chain information, the company needed new ways to join and relate…

biotechnology clinical trial computing covid covid-19 covid-19 pandemic data data sets information join life medicines pandemic paradigm peak pharmaceuticals real-time sponsored supply chain

Software Engineer for AI Training Data (School Specific)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Python)

@ G2i Inc | Remote

Software Engineer for AI Training Data (Tier 2)

@ G2i Inc | Remote

Data Engineer

@ Lemon.io | Remote: Europe, LATAM, Canada, UK, Asia, Oceania

Artificial Intelligence – Bioinformatic Expert

@ University of Texas Medical Branch | Galveston, TX

Lead Developer (AI)

@ Cere Network | San Francisco, US